Thiazolidinedione compounds
US5506245A · kind A · utility
6Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 1995 |
| Grant date | Apr 9, 1996 |
| Priority date | — |
| Expiry date | Jan 19, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compounds are 5-(4-substituted benzyl)thiazolidine-2,4-diones, enantiomers, diastereoisomers and pharmaceutically tolerable salts thereof, useful for treating conditions of insulin-resistance and/or non insulin-dependent diabetes. A compound disclosed is: .(R,S)-5-{4-[2-benzofuran-2-yl)carbonylamino)ethyl]benzyl}thiazolidine-2,4 -dione.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.